Separation of GVL from GVHD -location, location, location

Separation of GVL from GVHD -location, location, location

Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for various hematologic malignancies. However, alloimmune response is a double-edged sword that mediates both beneficial graft-versus-leukemia (GVL) effects and harmful graft-versus-host disease (GVHD). Separation of GVL effec...

Full description

Bibliographic Details
Main Authors:	Takanori Teshima, Daigo Hashimoto
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Immunology
Subjects:	graft-versus-leukemia graft-versus-host disease intestine tumor immune environment tissue tolerance
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1296663/full

Similar Items

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
by: Jacob Rozmus, et al.
Published: (2022-03-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
by: Sena Kim, et al.
Published: (2020-06-01)

Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity
by: Qingxiao Song, et al.
Published: (2022-05-01)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
by: Takahide Ara, et al.
Published: (2021-08-01)

Regulatory T Cells in GVHD Therapy
by: Wen-wen Guo, et al.
Published: (2021-06-01)

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
by: Fathima A. Mohamed, et al.
Published: (2021-10-01)

Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation
by: Yusuke Meguri, et al.
Published: (2022-08-01)

Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration
by: Yang Gao, et al.
Published: (2021-12-01)

MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease
by: Christian Koenecke, et al.
Published: (2018-05-01)

Biomarkers for Allogeneic HCT Outcomes
by: Djamilatou Adom, et al.
Published: (2020-04-01)

The Graft-Versus-Leukemia Effect in AML
by: Connor Sweeney, et al.
Published: (2019-11-01)

Current status of research and treatment of dry eye associated with chronic ocular graft-versus-host disease
by: Yuan Liang, et al.
Published: (2022-12-01)

Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial
by: Liren Qian, et al.
Published: (2020-11-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
by: Robin Reschke, et al.
Published: (2022-08-01)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
by: Hua Jiang, et al.
Published: (2021-10-01)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate
by: Jingjing Han, et al.
Published: (2017-11-01)

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells
by: Yong-Rim Kwon, et al.
Published: (2020-09-01)

Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
by: Ying-Jun Chang, et al.
Published: (2018-12-01)

CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model
by: Ji-Young Lim, et al.
Published: (2020-06-01)

Vitiligo: an uncommon cutaneous manifestation of graft versus host disease
by: Preema Sinha, et al.
Published: (2022-01-01)

Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01)

Lichenoid variant of chronic cutaneous graft versus host reaction post blood transfusion: A rare event post blood transfusion
by: Pushpa Kodipalya Ramakrishnaiah, et al.
Published: (2015-01-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
by: Hannes Schmid, et al.
Published: (2018-08-01)

Enfermedad injerto contra huesped: sus manifestaciones bucales
by: Claudia Marcela Hernández Cancino, et al.

The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models
by: Takanori Teshima, et al.
Published: (2021-08-01)

Donor lymphocyte infusion in bone marrow transplantation therapy
by: Stephen Mackinnon, et al.
Published: (2002-04-01)

Spontaneous xenogeneic GvHD in Wilms' tumor Patient‐Derived xenograft models and potential solutions
by: Seyed Mostafa Monzavi, et al.
Published: (2022-08-01)

Skin and kidney histological changes in graft-versus-host disease (GVHD) after kidney transplantation
by: Tadeja Pintar, et al.
Published: (2011-05-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Immune reconstitution after hematopoietic stem cell transplantation
by: Justyna Ogonek, et al.
Published: (2016-11-01)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
by: Israel Henig, et al.
Published: (2014-10-01)

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect
by: Eun Young Choi, et al.
Published: (2020-06-01)

Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD
by: Irina Kostareva, et al.
Published: (2022-09-01)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
by: Michael Stadler, et al.
Published: (2022-08-01)